We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Invalidates Synthon Patents, Cites Inequitable Conduct
Manufacturing methods used by Pfizer to produce its top-selling hypertension treatment drug Norvasc do not infringe on patents held by Synthon, a federal district court has ruled.